475 related articles for article (PubMed ID: 30819451)
1. Leptomeningeal carcinomatosis in patients with breast cancer.
Franzoi MA; Hortobagyi GN
Crit Rev Oncol Hematol; 2019 Mar; 135():85-94. PubMed ID: 30819451
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Markers and Histologic Subtypes in Patients with Meningeal Carcinomatosis in Breast Cancer.
Alnajar H; Rosen L; Javidiparsijani S; Al-Ghamdi Y; Gattuso P
Acta Cytol; 2017; 61(2):140-144. PubMed ID: 28231581
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer leptomeningeal metastasis: propensity of breast cancer subtypes for leptomeninges and the analysis of factors influencing survival.
Niwińska A; Rudnicka H; Murawska M
Med Oncol; 2013 Mar; 30(1):408. PubMed ID: 23322521
[TBL] [Abstract][Full Text] [Related]
4. Leptomeningeal carcinomatosis can be presenting manifestation of breast carcinoma.
Stojmenović GM; Pavlović AM; Gazibara MS; Grujicić D; Radojicić A; Sternić NC
Vojnosanit Pregl; 2016 Mar; 73(3):293-5. PubMed ID: 27295918
[TBL] [Abstract][Full Text] [Related]
5. [Effective systemic palliative chemotherapy for intracranial metastases of breast cancer].
Sipőcz I; Pintér T; Skaliczky Z; Kullmann T
Orv Hetil; 2016 Nov; 157(45):1809-1813. PubMed ID: 27817234
[TBL] [Abstract][Full Text] [Related]
6. Treatment and prognosis of leptomeningeal disease secondary to metastatic breast cancer: A single-centre experience.
Kingston B; Kayhanian H; Brooks C; Cox N; Chaabouni N; Redana S; Kalaitzaki E; Smith I; O'Brien M; Johnston S; Parton M; Noble J; Stanway S; Ring A; Turner N; Okines A
Breast; 2017 Dec; 36():54-59. PubMed ID: 28968585
[TBL] [Abstract][Full Text] [Related]
7. Implication of breast cancer phenotype for patients with leptomeningeal carcinomatosis.
Torrejón D; Oliveira M; Cortes J; Sanchez-Olle G; Gómez P; Bellet M; Saura C; Peg V; Rovira A; Di Cosimo S
Breast; 2013 Feb; 22(1):19-23. PubMed ID: 23137566
[TBL] [Abstract][Full Text] [Related]
8. The necessity of intrathecal chemotherapy for the treatment of breast cancer patients with leptomeningeal metastasis: A systematic review and pooled analysis.
Lee YC; Hsieh CC; Chuang JP; Li CY
Curr Probl Cancer; 2017; 41(5):355-370. PubMed ID: 28779849
[TBL] [Abstract][Full Text] [Related]
9. Phase II Study of Systemic High-dose Methotrexate and Intrathecal Liposomal Cytarabine for Treatment of Leptomeningeal Carcinomatosis From Breast Cancer.
Mrugala MM; Kim B; Sharma A; Johnson N; Graham C; Kurland BF; Gralow J
Clin Breast Cancer; 2019 Oct; 19(5):311-316. PubMed ID: 31175053
[TBL] [Abstract][Full Text] [Related]
10. [Leptomeningeal meningitis related to breast cancer overexpressing HER2: is there a place for a more specific treatment?].
Gutierrez M; Lyazidi S; Brasseur L; Cvitkovic F; Le Scodan R
Bull Cancer; 2011 Apr; 98(4):417-24. PubMed ID: 21540147
[TBL] [Abstract][Full Text] [Related]
11. Intrathecal Trastuzumab Treatment in Patients with Breast Cancer and Leptomeningeal Carcinomatosis.
Park WY; Kim HJ; Kim K; Bae SB; Lee N; Lee KT; Won JH; Park HS; Lee SC
Cancer Res Treat; 2016 Apr; 48(2):843-7. PubMed ID: 25761487
[TBL] [Abstract][Full Text] [Related]
12. [Intrathecal methotrexate in breast cancer meningeal carcinomatosis - Experience with a new administration schedule].
Cochereau D; Da Costa S; Le Maignan C; Gauthier H; Cochereau J; Espié M; Giacchetti S; Teixeira L
Bull Cancer; 2016 May; 103(5):444-54. PubMed ID: 26987841
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological and Treatment-Associated Prognostic Factors in Patients with Breast Cancer Leptomeningeal Metastases in Relation to Tumor Biology.
Griguolo G; Pouderoux S; Dieci MV; Jacot W; Bourgier C; Miglietta F; Firmin N; Conte P; Viala M; Guarneri V; Darlix A
Oncologist; 2018 Nov; 23(11):1289-1299. PubMed ID: 30120164
[TBL] [Abstract][Full Text] [Related]
14. Long-term complete response to intrathecal trastuzumab in a patient with leptomeningeal carcinomatosis due to her2- overexpressing breast cancer: Case report.
García FJV; Carrión NP; de la Cruz-Merino L
Medicine (Baltimore); 2020 Jan; 99(1):e18298. PubMed ID: 31895768
[TBL] [Abstract][Full Text] [Related]
15. Meningeal carcinomatosis in patients with breast carcinoma. Clinical features, prognostic factors, and results of a high-dose intrathecal methotrexate regimen.
Fizazi K; Asselain B; Vincent-Salomon A; Jouve M; Dieras V; Palangie T; Beuzeboc P; Dorval T; Pouillart P
Cancer; 1996 Apr; 77(7):1315-23. PubMed ID: 8608509
[TBL] [Abstract][Full Text] [Related]
16. Intrathecal administration of trastuzumab with cytarabine and methotrexate in breast cancer patients with leptomeningeal carcinomatosis.
Mego M; Sycova-Mila Z; Obertova J; Rajec J; Liskova S; Palacka P; Porsok S; Mardiak J
Breast; 2011 Oct; 20(5):478-80. PubMed ID: 21700455
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer leptomeningeal metastasis: the results of combined treatment and the comparison of methotrexate and liposomal cytarabine as intra-cerebrospinal fluid chemotherapy.
Niwińska A; Rudnicka H; Murawska M
Clin Breast Cancer; 2015 Feb; 15(1):66-72. PubMed ID: 25287959
[TBL] [Abstract][Full Text] [Related]
18. Triple intrathecal chemotherapy for leptomeningeal carcinomatosis in solid tumors: Treatment outcomes, response and their determinants.
Srinivasalu VK; Subramaniam N; Philip A; Jose W; Pavithran K
Indian J Cancer; 2021; 58(1):84-90. PubMed ID: 33402572
[TBL] [Abstract][Full Text] [Related]
19. Autocrine GMCSF Signaling Contributes to Growth of HER2
Ansari KI; Bhan A; Saotome M; Tyagi A; De Kumar B; Chen C; Takaku M; Jandial R
Cancer Res; 2021 Sep; 81(18):4723-4735. PubMed ID: 34247146
[TBL] [Abstract][Full Text] [Related]
20. Intrathecal administration of trastuzumab for the treatment of meningeal carcinomatosis in HER2-positive metastatic breast cancer: a systematic review and pooled analysis.
Zagouri F; Sergentanis TN; Bartsch R; Berghoff AS; Chrysikos D; de Azambuja E; Dimopoulos MA; Preusser M
Breast Cancer Res Treat; 2013 May; 139(1):13-22. PubMed ID: 23588955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]